The pharmaceuticals giant has exceeded Wall Street’s expectations for five straight quarters, helped by the success of its GLP-1 drugs for obesity.
Communicating your story to the Street
The pharmaceuticals giant has exceeded Wall Street’s expectations for five straight quarters, helped by the success of its GLP-1 drugs for obesity.